Endometrial cancer trials in Brazil
11 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Where
- Ipatinga, Passo Fundo, Porto Alegre, São José do Rio Preto, São Paulo
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06340568 · EU 2023-507525-42-00 - Phase 3Taking peopleA Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Where
- Goiânia, Natal, Porto Alegre, Rio de Janeiro, São Paulo
- Age
- 18 years and over
- People
- 1,123 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06952504 · EU 2024-519331-42-00 - Phase 3Taking peopleStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Where
- Porto Alegre, Rio de Janeiro, São Paulo
- Age
- 18 years and over
- People
- 660 worldwide
- Run by
- Genmab
See details and how to joinNCT07166094 - Phase 3Taking peopleA Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
- Where
- CuritibaPR, Porto Alegre, São Luís, São Paulo, Vitória
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07286331 · EU 2025-523362-25-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Barretos, Florianópolis, Jaú, Porto Alegre
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 3Taking peopleDESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Where
- Barretos, Belo Horizonte, Goiânia, Londrina, Porto Alegre, Rio de Janeiro, Salvador, São Paulo, Teresina
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06989112 · EU 2023-508056-19-00 - Phase 1/2Taking peopleA Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Where
- Barretos, Porto Alegre, São Paulo, Sorocaba
- Age
- 18 years and over
- People
- 612 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT04590326 · EU 2022-501904-83-00 - Phase 3Taking peopleSentinel Node Biopsy in Endometrial Cancer
- Where
- São José do Rio Preto, São Paulo
- Age
- 18 years and over
- People
- 760 worldwide
- Run by
- Queensland Centre for Gynaecological Cancer
See details and how to joinNCT04073706 - Phase 3Taking peoplePuxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Where
- Belém, Belo Horizonte, Bento Gonçalves, Blumenau, Curitiba, Florianópolis, Joinville, Natal, Porto Alegre, Recife, Ribeirão Preto, Rio de Janeiro, Salvador, São Caetano do Sul, São Paulo, Sorocaba, Taubaté, Teresina
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07044336 · EU 2024-518777-34-00 - No phaseTaking peopleOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
- Where
- São Paulo
- People
- 212 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT06689956 - No phaseNot yet taking people in BrazilProteomic Analysis of Patients Undergoing Bariatric Surgery
- Where
- Recife
- Age
- 18 years and over
- People
- 103
- Run by
- Universidade Federal de Pernambuco
See details and how to joinNCT06787807